Tuomas Knowles: key facts
- Kind of voice
- Academic
- Role
- Scientific co-founder, Ride Therapeutics; Professor at University of Cambridge
- Quoted on
- Rare diseases
- Tracked press citations
- 4
- Most recently quoted
- 29 Sept 2026
“Ride was launched in 2023 as a spin-out from Harvard University and the University of Cambridge to solve this challenge, utilizing technology from the labs of Ride's scientific co-founders, Professors David Weitz and Tuomas Knowles”
What Tuomas Knowles has said
“Ride was launched in 2023 as a spinout from Harvard University and the University of Cambridge, using technology developed in the laboratories of the company's scientific co-founders, David Weitz, PhD, and Tuomas Knowles, PhD.”
scientific co-founder of Ride · Rare diseases · 29 Sept 2026 · Ride to get up to $7.3M from CF Foundation for gene delivery tech ↗
“Ride Therapeutics co-founder Professor Tuomas Knowles”
co-founder of Ride Therapeutics · Rare diseases · 29 Sept 2026 · Ride Therapeutics in $7.3m boost from Cystic Fibrosis Foundation ↗
“Ride was launched in 2023 as a spinout of Harvard University and the University of Cambridge based on technology developed in the laboratories of scientific co-founders Professors David Weitz and Tuomas Knowles.”
Professor, scientific co-founder · Rare diseases · 21 Sept 2026 · Ride Therapeutics Secures Up To $7.3 Million From Cystic Fibrosis Foundation For AI-Designed Genetic Medicine Delivery ↗
Where Tuomas Knowles has been quoted
- Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicinessynbiobeta.com · 29 Sept 2026
- Ride to get up to $7.3M from CF Foundation for gene delivery techcysticfibrosisnewstoday.com · 29 Sept 2026
- Ride Therapeutics in $7.3m boost from Cystic Fibrosis Foundationcambridgeindependent.co.uk · 29 Sept 2026
- Ride Therapeutics Secures Up To $7.3 Million From Cystic Fibrosis Foundation For AI-Designed Genetic Medicine Deliverypulse2.com · 21 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.